317
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles

, , &
Pages 35-43 | Published online: 16 Dec 2010

References

  • BartalCDanonASchlaefferFPharmacokinetic dosing of aminoglycosides: a controlled trialAm J Med2003114319419812637133
  • SchiffelersRStormGBakker-WoudenbergILiposome-encapsulated aminoglycosides in pre-clinical and clinical studiesJ Antimicrob Chemother200148333334411532996
  • WilsonJFDavisACTobinCMEvaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessmentJ Antimicrob Chemother2003521788212805260
  • HammondLJGaldwellSCampbellPWCystic fibrosis, intravenous antibiotics, and home therapyJ Pediatr Health Care19915124301990112
  • ShahSMisraALiposomal amikacin dry powder inhaler: effect of fines on in vitro performanceAAPS Pharm Sci Tech200454e65
  • CullenABCoxCAHippSJWolfsonMRShafferTHIntra-tracheal delivery strategy of gentamicin with partial liquid ventilationResp Med19999311770778
  • AtyabiFTalaieFDinarvandRThiolated chitosan nanoparticles as an oral delivery system for amikacin: in vitro and ex vivo evaluationsJ Nanosci Nanotechnol2009984593460319928123
  • VarshosazJGhaffariSKhoshayandMRAtyabiFAzarmiSKobarfardFDevelopment and optimization of amikacin solid lipid nanoparticles by central composite designJ Liposome Res20102029710419621981
  • BaraniHMontazerMA review on applications of liposomes in textile processingJ Liposome Res200818324926218770074
  • MullerHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
  • ZhangNPingQHuangGXuWChengYHanXLecitin-modified solid lipid nanoparticles as carriers for oral administration of insulinInt J Pharm20063271215315916962267
  • SweetmanSCThe Complete Drug Reference35th edLondon, UKChicago Pharmaceutical Press (PhP)2007
  • BeaulacCSachetelliSLagaceJIn vitro bactericidal efficacy of sub-MIC concentration of liposome encapsulated antibiotic against gram- negative and gram- positive bacteriaJ Antimicrob Chemother199841135419511035
  • GazoriTKhoshayandMRAziziEYazdizadePNomaniAHaririanIEvalution of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization, and in vitro characterizationCarbohyd Polym2009773599606
  • VarshosazJGhaffariSKhoshayandMRAtyabiFOptimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental designPharm Dev Tech2010 In press
  • VivekKReddyHMurthyRInvestigation of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticlesAAPS Pharm Sci Tech2007841624
  • LarsonTAPetersonLRGerdingDNMicrodilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organismsJ Clin Microbiol19852258198213932459
  • SiddiqiSHeifetsLBCynamonMRapid broth macrodilution method for determination of MICs for Mycobacterium avium isolatesJ Clin Microbiol1993319233223388408551
  • BermudezLEWuMYoungLSIntracellular killing of Mycobacterium avium complex by rifapentine and liposome-incapsulated amikacinJ Infect Dis198715635105133611835
  • PoynerEAAlparHOAlmeidaAJGambleMDBrownMRWA comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal deliveryJ Control Rel19953514148